Cwm, LLC Veracyte, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Cwm, LLC holds 4,776 shares of VCYT stock, worth $195,290. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,776

Previous 1,516 215.04%

Holding current value

$195,290

Previous $33,000 393.94%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$21.0 - $35.25 $68,460 - $114,915	3,260 Added 215.04%	4,776 $163,000
Q2 2024 Jul 09, 2024	BUY	$18.86 - $23.55 $17,935 - $22,396	951 Added 168.32%	1,516 $33,000
Q1 2024 Apr 05, 2024	SELL	$21.0 - $29.1 $10,206 - $14,142	-486 Reduced 46.24%	565 $13,000
Q4 2023 Feb 01, 2024	SELL	$19.72 - $28.68 $21,593 - $31,404	-1,095 Reduced 51.03%	1,051 $29,000
Q3 2023 Oct 11, 2023	BUY	$22.33 - $29.92 $40,350 - $54,065	1,807 Added 533.04%	2,146 $48,000
Q2 2023 Aug 03, 2023	BUY	$20.96 - $26.99 $4,799 - $6,180	229 Added 208.18%	339 $9,000
Q1 2023 Apr 28, 2023	SELL	$20.58 - $27.89 $2,469 - $3,346	-120 Reduced 52.17%	110 $2,000
Q4 2022 Feb 01, 2023	SELL	$15.31 - $29.94 $8,726 - $17,065	-570 Reduced 71.25%	230 $5,000
Q3 2022 Oct 27, 2022	SELL	$16.58 - $27.9 $132 - $223	-8 Reduced 0.99%	800 $13,000
Q2 2022 Jul 28, 2022	BUY	$15.45 - $29.52 $12,066 - $23,055	781 Added 2892.59%	808 $16,000
Q1 2022 Apr 21, 2022	SELL	$21.94 - $42.51 $394 - $765	-18 Reduced 40.0%	27 $1,000
Q4 2021 Jan 31, 2022	BUY	$36.09 - $53.79 $433 - $645	12 Added 36.36%	45 $2,000
Q1 2021 Sep 15, 2021	BUY	$44.47 - $81.38 $1,467 - $2,685	33 New	33 $1,000
Q1 2021 Apr 27, 2021	SELL	$44.47 - $81.38 $1,467 - $2,685	-33 Closed	0 $0
Q4 2020 Sep 15, 2021	BUY	$32.49 - $61.88 $1,072 - $2,042	33 New	33 $1,000
Q4 2020 Jan 27, 2021	SELL	$32.49 - $61.88 $1,072 - $2,042	-33 Closed	0 $0
Q3 2020 Sep 15, 2021	BUY	$26.73 - $35.67 $882 - $1,177	33 New	33 $1,000
Q3 2020 Oct 19, 2020	SELL	$26.73 - $35.67 $882 - $1,177	-33 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	$19.49 - $28.11 $643 - $927	33 New	33 $1,000
Q2 2020 Jul 22, 2020	SELL	$19.49 - $28.11 $643 - $927	-33 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$16.13 - $30.17 $532 - $995	33 New	33 $1,000
Q1 2020 Apr 28, 2020	SELL	$16.13 - $30.17 $532 - $995	-33 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$20.78 - $29.99 $685 - $989	33 New	33 $1,000
Q4 2019 Jan 27, 2020	SELL	$20.78 - $29.99 $685 - $989	-33 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$23.87 - $30.93 $787 - $1,020	33 New	33 $1,000
Q3 2019 Oct 22, 2019	SELL	$23.87 - $30.93 $787 - $1,020	-33 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$22.1 - $28.56 $729 - $942	33 New	33 $1,000
Q2 2019 Jul 31, 2019	SELL	$22.1 - $28.56 $729 - $942	-33 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$12.0 - $25.76 $396 - $850	33 New	33 $0

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.7M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.93B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account